Blafarm's point is that 1.) we don't have the dose

Quote:

---

Blafarm's point is that 1.) we don't have the dose escalation data for covid at 350mg, 2.) we know there is no risk to 700mg, and 3.) the company's financial fuse is short - why risk it?

Call me what you want - I have very thick skin. I want the trial to work and the company to be successful.

---

Worth remembering the 700mg followed by 3x 350mg is the mild/moderate trial.

Critical is 4 x weekly 700mg via IV. I don't think we need to worry too much about that trial being successful. We're going to crush it.